Write a reviewFor vendors
♡
Home / Investors / Startups / Boundless Bio

Boundless Bio

Boundless Bio is a precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers.
boundlessbio.com ↗LinkedInX / Twitter

About Boundless Bio

Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers. Boundless Bio was founded in 2018 and is headquartered in La Jolla, California.

Industries

BioTechHealthcareLife Science

Investors in Boundless Bio (4)

Vertex Ventures

Venture Fund · Palo Alto, Singapore · Founded 1988
SeedSeries ASeries BSeries CArtificial Intelligence & Machine Learning (AI/ML)Developer ToolsSoftwareQuality Assurance+32
454Investments
94Exits

ARCH Venture Partners

Venture Fund · Chicago, Illinois · Founded 1986
Pre-SeedSeedSeries AHealthcareMedical DeviceProductivity ToolsHealth & Wellness+15
418Investments
98Exits

RA Capital Management

Venture Fund · Boston, Massachusetts · Founded 2001
Pre-SeedSeedSeries ASeries BHealthcareMedical DeviceHealth & WellnessBioTech+3
288Investments
140Exits

Alexandria Venture Investments

Venture Fund · Pasadena, California · Founded 1996
BioTechMedical DevicePharmaceuticalsHealthcare+11
191Investments
34Exits